New vaginal insert aims to clear persistent HPV in women
NCT ID NCT06491446
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental vaginal insert (ABI-2280) to see if it can safely clear persistent high-risk human papillomavirus (HPV) infection in women aged 25 to 55. Participants must have had HPV for at least a year with no serious cervical changes. The study compares different doses against a placebo to check safety and how well the virus is cleared.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arke Estudios Clinicos S.A. De C.V.
Cuauhtémoc, CP 06700, Mexico
-
AusTrials Taringa
Taringa, Australia
-
AusTrials Wellers Hill
Tarragindi, Australia
-
Centro Oncologico Internacional
Mexico City, CP 04700, Mexico
-
Clinical Horizons New Zealand
Tauranga, New Zealand
-
Emeritus Research Camberwell
Camberwell, Australia
-
Emeritus Research Sydney
Sydney, Australia
-
FAICIC S. de R.L. de C.V.
Veracruz, CP 91900, Mexico
-
Holdsworth House Medical Practice
Darlinghurst, Australia
-
International Cancer Institute
Eldoret, 8088-30100, Kenya
-
KIMR
Nedlands, Australia
-
Kenya Medical Research Institute (KEMRI) - RCTP Kisumu
Kisumu, 614-40100, Kenya
-
Lakeland Clinical Trials
Rotorua, New Zealand
-
P3 Research Dunedin
Dunedin, New Zealand
-
P3 Research Hawke's Bay
Hastings, New Zealand
-
P3 Research Kapiti
Paraparaumu, New Zealand
-
P3 Research Lower Hutt
Lower Hutt, New Zealand
-
PARC Clinical Research, Royal Adelaide Hospital
Adelaide, South Australia, Australia
-
Pacific Clinical Trials Network - Tasman
Nelson, New Zealand
-
The Royal Women's Hospital
Parkville, Australia
-
Unidad de Medicina Especializada SMA
Querétaro, CP 76800, Mexico
-
Victoria Biomedical Research Institute
Kisumu, 7180-40100, Kenya
-
Victoria Cancer Care & Research Centres
Kisii, 1376-40500, Kenya
-
Waitemata Clinical Research Ltd
Birkenhead, New Zealand